No. |
KEGG PATHWAY * On map, Yellow: Drug target, Red: Disease-related |
KEGG GENES * |
KEGG DRUG * |
DrugBank |
指定難病告示番号 * |
1 | Acute myeloid leukemia 1 gene, 2 drugs (DrugBank) and 37 diseases shown |
1件: MTOR |
D02714 |
Everolimus |
9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
2 | Adherens junction 1 gene, 1 drug (DrugBank) and 2 diseases shown |
1件: SRC |
D03252 |
Bosutinib |
2件: 2, 67 |
3 | Adipocytokine signaling pathway 3 genes, 3 drugs (DrugBank) and 47 diseases shown |
1件: MTOR |
D02714 |
Everolimus |
9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
2件: PRKAA1, PRKAA2 |
D00944 |
Metformin |
17件: 6, 13, 46, 49, 67, 75, 77, 81, 86, 113, 158, 206, 225, 233, 265, 285, 299 |
D04966 |
4 | Adrenergic signaling in cardiomyocytes 9 genes, 8 drugs (DrugBank) and 23 diseases shown |
3件: ADRA1A, ADRA1B, ADRA1D |
D00608 |
Doxazosin |
2件: 57, 67 |
D07874 |
1件: ADRB1 |
D00634 |
Bisoprolol |
3件: 67, 86, 113 |
D02342 |
1件: AGTR1 |
D00522 |
Candesartan |
2件: 58, 67 |
D00522 |
Candesartan cilexetil |
2件: 58, 67 |
D00626 |
D00357 |
Losartan |
18件: 13, 17, 19, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 |
D08146 |
D00627 |
Telmisartan |
2件: 66, 67 |
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D00615 |
Amlodipine |
4件: 51, 65, 67, 298 |
D02914 |
D07450 |
D01173 |
Cilnidipine |
1件: 67 |
5 | AGE-RAGE signaling pathway in diabetic complications 1 gene, 4 drugs (DrugBank) and 18 diseases shown |
1件: AGTR1 |
D00522 |
Candesartan |
2件: 58, 67 |
D00522 |
Candesartan cilexetil |
2件: 58, 67 |
D00626 |
D00357 |
Losartan |
18件: 13, 17, 19, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 |
D08146 |
D00627 |
Telmisartan |
2件: 66, 67 |
6 | Aldosterone synthesis and secretion 5 genes, 6 drugs (DrugBank) and 21 diseases shown |
1件: AGTR1 |
D00522 |
Candesartan |
2件: 58, 67 |
D00522 |
Candesartan cilexetil |
2件: 58, 67 |
D00626 |
D00357 |
Losartan |
18件: 13, 17, 19, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 |
D08146 |
D00627 |
Telmisartan |
2件: 66, 67 |
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D00615 |
Amlodipine |
4件: 51, 65, 67, 298 |
D02914 |
D07450 |
D01173 |
Cilnidipine |
1件: 67 |
7 | Aldosterone-regulated sodium reabsorption 1 gene, 1 drug (DrugBank) and 6 diseases shown |
1件: NR3C2 |
D00443 |
Spironolactone |
6件: 58, 67, 86, 113, 218, 225 |
8 | Alzheimer disease 4 genes, 2 drugs (DrugBank) and 4 diseases shown |
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D00615 |
Amlodipine |
4件: 51, 65, 67, 298 |
D02914 |
D07450 |
D01173 |
Cilnidipine |
1件: 67 |
9 | Amphetamine addiction 2 genes, 2 drugs (DrugBank) and 4 diseases shown |
2件: CACNA1C, CACNA1D |
D00615 |
Amlodipine |
4件: 51, 65, 67, 298 |
D02914 |
D07450 |
D01173 |
Cilnidipine |
1件: 67 |
10 | AMPK signaling pathway 6 genes, 6 drugs (DrugBank) and 55 diseases shown |
1件: ADRA1A |
D00608 |
Doxazosin |
2件: 57, 67 |
D07874 |
1件: HMGCR |
D00893 |
Pravastatin |
9件: 13, 46, 49, 67, 79, 96, 164, 265, 333 |
D08410 |
1件: MTOR |
D02714 |
Everolimus |
9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
1件: PPARG |
D00945 |
Pioglitazone |
17件: 2, 6, 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299 |
D08378 |
2件: PRKAA1, PRKAA2 |
D00944 |
Metformin |
17件: 6, 13, 46, 49, 67, 75, 77, 81, 86, 113, 158, 206, 225, 233, 265, 285, 299 |
D04966 |
11 | Apelin signaling pathway 4 genes, 7 drugs (DrugBank) and 54 diseases shown |
1件: AGTR1 |
D00522 |
Candesartan |
2件: 58, 67 |
D00522 |
Candesartan cilexetil |
2件: 58, 67 |
D00626 |
D00357 |
Losartan |
18件: 13, 17, 19, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 |
D08146 |
D00627 |
Telmisartan |
2件: 66, 67 |
1件: MTOR |
D02714 |
Everolimus |
9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
2件: PRKAA1, PRKAA2 |
D00944 |
Metformin |
17件: 6, 13, 46, 49, 67, 75, 77, 81, 86, 113, 158, 206, 225, 233, 265, 285, 299 |
D04966 |
12 | Arrhythmogenic right ventricular cardiomyopathy (ARVC) 4 genes, 2 drugs (DrugBank) and 4 diseases shown |
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D00615 |
Amlodipine |
4件: 51, 65, 67, 298 |
D02914 |
D07450 |
D01173 |
Cilnidipine |
1件: 67 |
13 | Autophagy - animal 3 genes, 3 drugs (DrugBank) and 47 diseases shown |
1件: MTOR |
D02714 |
Everolimus |
9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
2件: PRKAA1, PRKAA2 |
D00944 |
Metformin |
17件: 6, 13, 46, 49, 67, 75, 77, 81, 86, 113, 158, 206, 225, 233, 265, 285, 299 |
D04966 |
14 | Autophagy - other 1 gene, 2 drugs (DrugBank) and 37 diseases shown |
1件: MTOR |
D02714 |
Everolimus |
9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
15 | Axon guidance 2 genes, 1 drug (DrugBank) and 2 diseases shown |
2件: ABL1, SRC |
D03252 |
Bosutinib |
2件: 2, 67 |
16 | Bacterial invasion of epithelial cells 1 gene, 1 drug (DrugBank) and 2 diseases shown |
1件: SRC |
D03252 |
Bosutinib |
2件: 2, 67 |
17 | beta-Alanine metabolism 1 gene, 1 drug (DrugBank) and 1 disease shown |
1件: AOC3 |
D08044 |
Hydralazine |
1件: 67 |
18 | Bile secretion 2 genes, 2 drugs (DrugBank) and 19 diseases shown |
1件: HMGCR |
D00893 |
Pravastatin |
9件: 13, 46, 49, 67, 79, 96, 164, 265, 333 |
D08410 |
1件: NR1H4 |
D00734 |
Ursodeoxycholic acid |
12件: 6, 8, 20, 67, 84, 93, 94, 95, 96, 97, 234, 299 |
19 | Bladder cancer 1 gene, 1 drug (DrugBank) and 2 diseases shown |
1件: SRC |
D03252 |
Bosutinib |
2件: 2, 67 |
20 | Breast cancer 1 gene, 2 drugs (DrugBank) and 37 diseases shown |
1件: MTOR |
D02714 |
Everolimus |
9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
21 | C-type lectin receptor signaling pathway 1 gene, 1 drug (DrugBank) and 2 diseases shown |
1件: SRC |
D03252 |
Bosutinib |
2件: 2, 67 |
22 | Calcium signaling pathway 10 genes, 8 drugs (DrugBank) and 23 diseases shown |
3件: ADRA1A, ADRA1B, ADRA1D |
D00608 |
Doxazosin |
2件: 57, 67 |
D07874 |
1件: ADRB1 |
D00634 |
Bisoprolol |
3件: 67, 86, 113 |
D02342 |
1件: AGTR1 |
D00522 |
Candesartan |
2件: 58, 67 |
D00522 |
Candesartan cilexetil |
2件: 58, 67 |
D00626 |
D00357 |
Losartan |
18件: 13, 17, 19, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 |
D08146 |
D00627 |
Telmisartan |
2件: 66, 67 |
5件: CACNA1B, CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D01173 |
Cilnidipine |
1件: 67 |
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D00615 |
Amlodipine |
4件: 51, 65, 67, 298 |
D02914 |
D07450 |
23 | cAMP signaling pathway 8 genes, 6 drugs (DrugBank) and 15 diseases shown |
1件: ADRB1 |
D00634 |
Bisoprolol |
3件: 67, 86, 113 |
D02342 |
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D00615 |
Amlodipine |
4件: 51, 65, 67, 298 |
D02914 |
D07450 |
D01173 |
Cilnidipine |
1件: 67 |
3件: SSTR1, SSTR2, SSTR5 |
D10147 |
Pasireotide |
3件: 67, 74, 75 |
D07431 |
Somatostatin |
2件: 67, 78 |
1件: SSTR2 |
D00442 |
Octreotide |
8件: 67, 75, 84, 85, 89, 96, 193, 227 |
D06495 |
24 | Carbohydrate digestion and absorption 1 gene, 2 drugs (DrugBank) and 4 diseases shown |
1件: CACNA1D |
D00615 |
Amlodipine |
4件: 51, 65, 67, 298 |
D02914 |
D07450 |
D01173 |
Cilnidipine |
1件: 67 |
25 | Cardiac muscle contraction 4 genes, 2 drugs (DrugBank) and 4 diseases shown |
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D00615 |
Amlodipine |
4件: 51, 65, 67, 298 |
D02914 |
D07450 |
D01173 |
Cilnidipine |
1件: 67 |
26 | Cell cycle 1 gene, 1 drug (DrugBank) and 2 diseases shown |
1件: ABL1 |
D03252 |
Bosutinib |
2件: 2, 67 |
27 | Cellular senescence 2 genes, 4 drugs (DrugBank) and 38 diseases shown |
1件: CACNA1D |
D00615 |
Amlodipine |
4件: 51, 65, 67, 298 |
D02914 |
D07450 |
D01173 |
Cilnidipine |
1件: 67 |
1件: MTOR |
D02714 |
Everolimus |
9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
28 | Central carbon metabolism in cancer 1 gene, 2 drugs (DrugBank) and 37 diseases shown |
1件: MTOR |
D02714 |
Everolimus |
9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
29 | cGMP-PKG signaling pathway 9 genes, 8 drugs (DrugBank) and 23 diseases shown |
3件: ADRA1A, ADRA1B, ADRA1D |
D00608 |
Doxazosin |
2件: 57, 67 |
D07874 |
1件: ADRB1 |
D00634 |
Bisoprolol |
3件: 67, 86, 113 |
D02342 |
1件: AGTR1 |
D00522 |
Candesartan |
2件: 58, 67 |
D00522 |
Candesartan cilexetil |
2件: 58, 67 |
D00626 |
D00357 |
Losartan |
18件: 13, 17, 19, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 |
D08146 |
D00627 |
Telmisartan |
2件: 66, 67 |
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D00615 |
Amlodipine |
4件: 51, 65, 67, 298 |
D02914 |
D07450 |
D01173 |
Cilnidipine |
1件: 67 |
30 | Chagas disease (American trypanosomiasis) 1 gene, 3 drugs (DrugBank) and 8 diseases shown |
1件: ACE |
D08068 |
Imidapril |
1件: 67 |
D00362 |
Lisinopril |
5件: 46, 66, 67, 113, 222 |
D08131 |
D00421 |
Ramipril |
7件: 46, 49, 66, 67, 113, 218, 257 |
31 | Chemokine signaling pathway 1 gene, 1 drug (DrugBank) and 2 diseases shown |
1件: SRC |
D03252 |
Bosutinib |
2件: 2, 67 |
32 | Choline metabolism in cancer 1 gene, 2 drugs (DrugBank) and 37 diseases shown |
1件: MTOR |
D02714 |
Everolimus |
9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
33 | Cholinergic synapse 5 genes, 2 drugs (DrugBank) and 4 diseases shown |
5件: CACNA1B, CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D01173 |
Cilnidipine |
1件: 67 |
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D00615 |
Amlodipine |
4件: 51, 65, 67, 298 |
D02914 |
D07450 |
34 | Chronic myeloid leukemia 1 gene, 1 drug (DrugBank) and 2 diseases shown |
1件: ABL1 |
D03252 |
Bosutinib |
2件: 2, 67 |
35 | Circadian entrainment 2 genes, 2 drugs (DrugBank) and 4 diseases shown |
2件: CACNA1C, CACNA1D |
D00615 |
Amlodipine |
4件: 51, 65, 67, 298 |
D02914 |
D07450 |
D01173 |
Cilnidipine |
1件: 67 |
36 | Circadian rhythm 2 genes, 1 drug (DrugBank) and 17 diseases shown |
2件: PRKAA1, PRKAA2 |
D00944 |
Metformin |
17件: 6, 13, 46, 49, 67, 75, 77, 81, 86, 113, 158, 206, 225, 233, 265, 285, 299 |
D04966 |
37 | Colorectal cancer 1 gene, 2 drugs (DrugBank) and 37 diseases shown |
1件: MTOR |
D02714 |
Everolimus |
9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
38 | Cortisol synthesis and secretion 5 genes, 6 drugs (DrugBank) and 21 diseases shown |
1件: AGTR1 |
D00522 |
Candesartan |
2件: 58, 67 |
D00522 |
Candesartan cilexetil |
2件: 58, 67 |
D00626 |
D00357 |
Losartan |
18件: 13, 17, 19, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 |
D08146 |
D00627 |
Telmisartan |
2件: 66, 67 |
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D00615 |
Amlodipine |
4件: 51, 65, 67, 298 |
D02914 |
D07450 |
D01173 |
Cilnidipine |
1件: 67 |
39 | Cushing syndrome 5 genes, 6 drugs (DrugBank) and 21 diseases shown |
1件: AGTR1 |
D00522 |
Candesartan |
2件: 58, 67 |
D00522 |
Candesartan cilexetil |
2件: 58, 67 |
D00626 |
D00357 |
Losartan |
18件: 13, 17, 19, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 |
D08146 |
D00627 |
Telmisartan |
2件: 66, 67 |
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D00615 |
Amlodipine |
4件: 51, 65, 67, 298 |
D02914 |
D07450 |
D01173 |
Cilnidipine |
1件: 67 |
40 | Dilated cardiomyopathy (DCM) 5 genes, 3 drugs (DrugBank) and 6 diseases shown |
1件: ADRB1 |
D00634 |
Bisoprolol |
3件: 67, 86, 113 |
D02342 |
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D00615 |
Amlodipine |
4件: 51, 65, 67, 298 |
D02914 |
D07450 |
D01173 |
Cilnidipine |
1件: 67 |
41 | Dopaminergic synapse 3 genes, 2 drugs (DrugBank) and 4 diseases shown |
3件: CACNA1B, CACNA1C, CACNA1D |
D01173 |
Cilnidipine |
1件: 67 |
2件: CACNA1C, CACNA1D |
D00615 |
Amlodipine |
4件: 51, 65, 67, 298 |
D02914 |
D07450 |
42 | EGFR tyrosine kinase inhibitor resistance 2 genes, 3 drugs (DrugBank) and 37 diseases shown |
1件: MTOR |
D02714 |
Everolimus |
9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
1件: SRC |
D03252 |
Bosutinib |
2件: 2, 67 |
43 | Endocrine resistance 2 genes, 3 drugs (DrugBank) and 37 diseases shown |
1件: MTOR |
D02714 |
Everolimus |
9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
1件: SRC |
D03252 |
Bosutinib |
2件: 2, 67 |
44 | Endocytosis 1 gene, 1 drug (DrugBank) and 2 diseases shown |
1件: SRC |
D03252 |
Bosutinib |
2件: 2, 67 |
45 | Epithelial cell signaling in Helicobacter pylori infection 1 gene, 1 drug (DrugBank) and 2 diseases shown |
1件: SRC |
D03252 |
Bosutinib |
2件: 2, 67 |
46 | ErbB signaling pathway 3 genes, 3 drugs (DrugBank) and 37 diseases shown |
2件: ABL1, SRC |
D03252 |
Bosutinib |
2件: 2, 67 |
1件: MTOR |
D02714 |
Everolimus |
9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
47 | Estrogen signaling pathway 1 gene, 1 drug (DrugBank) and 2 diseases shown |
1件: SRC |
D03252 |
Bosutinib |
2件: 2, 67 |
48 | Fluid shear stress and atherosclerosis 3 genes, 2 drugs (DrugBank) and 18 diseases shown |
2件: PRKAA1, PRKAA2 |
D00944 |
Metformin |
17件: 6, 13, 46, 49, 67, 75, 77, 81, 86, 113, 158, 206, 225, 233, 265, 285, 299 |
D04966 |
1件: SRC |
D03252 |
Bosutinib |
2件: 2, 67 |
49 | Focal adhesion 1 gene, 1 drug (DrugBank) and 2 diseases shown |
1件: SRC |
D03252 |
Bosutinib |
2件: 2, 67 |
50 | FoxO signaling pathway 2 genes, 1 drug (DrugBank) and 17 diseases shown |
2件: PRKAA1, PRKAA2 |
D00944 |
Metformin |
17件: 6, 13, 46, 49, 67, 75, 77, 81, 86, 113, 158, 206, 225, 233, 265, 285, 299 |
D04966 |
51 | GABAergic synapse 6 genes, 3 drugs (DrugBank) and 5 diseases shown |
5件: CACNA1B, CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D01173 |
Cilnidipine |
1件: 67 |
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D00615 |
Amlodipine |
4件: 51, 65, 67, 298 |
D02914 |
D07450 |
1件: SRC |
D03252 |
Bosutinib |
2件: 2, 67 |
52 | Gap junction 2 genes, 2 drugs (DrugBank) and 4 diseases shown |
1件: ADRB1 |
D00634 |
Bisoprolol |
3件: 67, 86, 113 |
D02342 |
1件: SRC |
D03252 |
Bosutinib |
2件: 2, 67 |
53 | Gastric acid secretion 1 gene, 3 drugs (DrugBank) and 10 diseases shown |
1件: SSTR2 |
D00442 |
Octreotide |
8件: 67, 75, 84, 85, 89, 96, 193, 227 |
D06495 |
D10147 |
Pasireotide |
3件: 67, 74, 75 |
D07431 |
Somatostatin |
2件: 67, 78 |
54 | Gastric cancer 1 gene, 2 drugs (DrugBank) and 37 diseases shown |
1件: MTOR |
D02714 |
Everolimus |
9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
55 | Glioma 1 gene, 2 drugs (DrugBank) and 37 diseases shown |
1件: MTOR |
D02714 |
Everolimus |
9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
56 | Glucagon signaling pathway 2 genes, 1 drug (DrugBank) and 17 diseases shown |
2件: PRKAA1, PRKAA2 |
D00944 |
Metformin |
17件: 6, 13, 46, 49, 67, 75, 77, 81, 86, 113, 158, 206, 225, 233, 265, 285, 299 |
D04966 |
57 | Glutamatergic synapse 2 genes, 2 drugs (DrugBank) and 4 diseases shown |
2件: CACNA1C, CACNA1D |
D00615 |
Amlodipine |
4件: 51, 65, 67, 298 |
D02914 |
D07450 |
D01173 |
Cilnidipine |
1件: 67 |
58 | Glycine, serine and threonine metabolism 1 gene, 1 drug (DrugBank) and 1 disease shown |
1件: AOC3 |
D08044 |
Hydralazine |
1件: 67 |
59 | GnRH secretion 4 genes, 2 drugs (DrugBank) and 4 diseases shown |
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D00615 |
Amlodipine |
4件: 51, 65, 67, 298 |
D02914 |
D07450 |
D01173 |
Cilnidipine |
1件: 67 |
60 | GnRH signaling pathway 5 genes, 3 drugs (DrugBank) and 5 diseases shown |
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D00615 |
Amlodipine |
4件: 51, 65, 67, 298 |
D02914 |
D07450 |
D01173 |
Cilnidipine |
1件: 67 |
1件: SRC |
D03252 |
Bosutinib |
2件: 2, 67 |
61 | Growth hormone synthesis, secretion and action 9 genes, 7 drugs (DrugBank) and 44 diseases shown |
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D00615 |
Amlodipine |
4件: 51, 65, 67, 298 |
D02914 |
D07450 |
D01173 |
Cilnidipine |
1件: 67 |
1件: MTOR |
D02714 |
Everolimus |
9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
4件: SSTR1, SSTR2, SSTR3, SSTR5 |
D10147 |
Pasireotide |
3件: 67, 74, 75 |
D07431 |
Somatostatin |
2件: 67, 78 |
1件: SSTR2 |
D00442 |
Octreotide |
8件: 67, 75, 84, 85, 89, 96, 193, 227 |
D06495 |
62 | Hepatitis B 1 gene, 1 drug (DrugBank) and 2 diseases shown |
1件: SRC |
D03252 |
Bosutinib |
2件: 2, 67 |
63 | Hepatocellular carcinoma 1 gene, 2 drugs (DrugBank) and 37 diseases shown |
1件: MTOR |
D02714 |
Everolimus |
9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
64 | Herpes simplex virus 1 infection 2 genes, 3 drugs (DrugBank) and 37 diseases shown |
1件: MTOR |
D02714 |
Everolimus |
9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
1件: SRC |
D03252 |
Bosutinib |
2件: 2, 67 |
65 | HIF-1 signaling pathway 1 gene, 2 drugs (DrugBank) and 37 diseases shown |
1件: MTOR |
D02714 |
Everolimus |
9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
66 | Human cytomegalovirus infection 2 genes, 3 drugs (DrugBank) and 37 diseases shown |
1件: MTOR |
D02714 |
Everolimus |
9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
1件: SRC |
D03252 |
Bosutinib |
2件: 2, 67 |
67 | Human immunodeficiency virus 1 infection 1 gene, 2 drugs (DrugBank) and 37 diseases shown |
1件: MTOR |
D02714 |
Everolimus |
9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
68 | Human papillomavirus infection 1 gene, 2 drugs (DrugBank) and 37 diseases shown |
1件: MTOR |
D02714 |
Everolimus |
9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
69 | Huntington disease 1 gene, 1 drug (DrugBank) and 17 diseases shown |
1件: PPARG |
D00945 |
Pioglitazone |
17件: 2, 6, 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299 |
D08378 |
70 | Hypertrophic cardiomyopathy (HCM) 7 genes, 6 drugs (DrugBank) and 24 diseases shown |
1件: ACE |
D08068 |
Imidapril |
1件: 67 |
D00362 |
Lisinopril |
5件: 46, 66, 67, 113, 222 |
D08131 |
D00421 |
Ramipril |
7件: 46, 49, 66, 67, 113, 218, 257 |
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D00615 |
Amlodipine |
4件: 51, 65, 67, 298 |
D02914 |
D07450 |
D01173 |
Cilnidipine |
1件: 67 |
2件: PRKAA1, PRKAA2 |
D00944 |
Metformin |
17件: 6, 13, 46, 49, 67, 75, 77, 81, 86, 113, 158, 206, 225, 233, 265, 285, 299 |
D04966 |
71 | Inflammatory mediator regulation of TRP channels 1 gene, 1 drug (DrugBank) and 2 diseases shown |
1件: SRC |
D03252 |
Bosutinib |
2件: 2, 67 |
72 | Insulin resistance 3 genes, 3 drugs (DrugBank) and 47 diseases shown |
1件: MTOR |
D02714 |
Everolimus |
9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
2件: PRKAA1, PRKAA2 |
D00944 |
Metformin |
17件: 6, 13, 46, 49, 67, 75, 77, 81, 86, 113, 158, 206, 225, 233, 265, 285, 299 |
D04966 |
73 | Insulin secretion 4 genes, 2 drugs (DrugBank) and 4 diseases shown |
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D00615 |
Amlodipine |
4件: 51, 65, 67, 298 |
D02914 |
D07450 |
D01173 |
Cilnidipine |
1件: 67 |
74 | Insulin signaling pathway 3 genes, 3 drugs (DrugBank) and 47 diseases shown |
1件: MTOR |
D02714 |
Everolimus |
9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
2件: PRKAA1, PRKAA2 |
D00944 |
Metformin |
17件: 6, 13, 46, 49, 67, 75, 77, 81, 86, 113, 158, 206, 225, 233, 265, 285, 299 |
D04966 |
75 | JAK-STAT signaling pathway 1 gene, 2 drugs (DrugBank) and 37 diseases shown |
1件: MTOR |
D02714 |
Everolimus |
9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
76 | Kaposi sarcoma-associated herpesvirus infection 2 genes, 3 drugs (DrugBank) and 37 diseases shown |
1件: MTOR |
D02714 |
Everolimus |
9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
1件: SRC |
D03252 |
Bosutinib |
2件: 2, 67 |
77 | Long-term potentiation 1 gene, 2 drugs (DrugBank) and 4 diseases shown |
1件: CACNA1C |
D00615 |
Amlodipine |
4件: 51, 65, 67, 298 |
D02914 |
D07450 |
D01173 |
Cilnidipine |
1件: 67 |
78 | Longevity regulating pathway 4 genes, 4 drugs (DrugBank) and 51 diseases shown |
1件: MTOR |
D02714 |
Everolimus |
9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
1件: PPARG |
D00945 |
Pioglitazone |
17件: 2, 6, 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299 |
D08378 |
2件: PRKAA1, PRKAA2 |
D00944 |
Metformin |
17件: 6, 13, 46, 49, 67, 75, 77, 81, 86, 113, 158, 206, 225, 233, 265, 285, 299 |
D04966 |
79 | Longevity regulating pathway - multiple species 3 genes, 3 drugs (DrugBank) and 47 diseases shown |
1件: MTOR |
D02714 |
Everolimus |
9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
2件: PRKAA1, PRKAA2 |
D00944 |
Metformin |
17件: 6, 13, 46, 49, 67, 75, 77, 81, 86, 113, 158, 206, 225, 233, 265, 285, 299 |
D04966 |
80 | MAPK signaling pathway 5 genes, 2 drugs (DrugBank) and 4 diseases shown |
5件: CACNA1B, CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D01173 |
Cilnidipine |
1件: 67 |
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D00615 |
Amlodipine |
4件: 51, 65, 67, 298 |
D02914 |
D07450 |
81 | Metabolic pathways 3 genes, 3 drugs (DrugBank) and 10 diseases shown |
1件: AOC3 |
D08044 |
Hydralazine |
1件: 67 |
1件: HMGCR |
D00893 |
Pravastatin |
9件: 13, 46, 49, 67, 79, 96, 164, 265, 333 |
D08410 |
1件: UGCG |
D11633 |
Venglustat |
2件: 19, 67 |
82 | MicroRNAs in cancer 2 genes, 3 drugs (DrugBank) and 37 diseases shown |
1件: ABL1 |
D03252 |
Bosutinib |
2件: 2, 67 |
1件: MTOR |
D02714 |
Everolimus |
9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
83 | Mitophagy - animal 1 gene, 1 drug (DrugBank) and 2 diseases shown |
1件: SRC |
D03252 |
Bosutinib |
2件: 2, 67 |
84 | Morphine addiction 1 gene, 1 drug (DrugBank) and 1 disease shown |
1件: CACNA1B |
D01173 |
Cilnidipine |
1件: 67 |
85 | mTOR signaling pathway 3 genes, 3 drugs (DrugBank) and 47 diseases shown |
1件: MTOR |
D02714 |
Everolimus |
9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
2件: PRKAA1, PRKAA2 |
D00944 |
Metformin |
17件: 6, 13, 46, 49, 67, 75, 77, 81, 86, 113, 158, 206, 225, 233, 265, 285, 299 |
D04966 |
86 | Neuroactive ligand-receptor interaction 11 genes, 11 drugs (DrugBank) and 29 diseases shown |
3件: ADRA1A, ADRA1B, ADRA1D |
D00608 |
Doxazosin |
2件: 57, 67 |
D07874 |
1件: ADRB1 |
D00634 |
Bisoprolol |
3件: 67, 86, 113 |
D02342 |
1件: AGTR1 |
D00522 |
Candesartan |
2件: 58, 67 |
D00522 |
Candesartan cilexetil |
2件: 58, 67 |
D00626 |
D00357 |
Losartan |
18件: 13, 17, 19, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 |
D08146 |
D00627 |
Telmisartan |
2件: 66, 67 |
1件: AVPR2 |
D04752 |
Lixivaptan |
1件: 67 |
D01213 |
Tolvaptan |
3件: 67, 72, 225 |
5件: SSTR1, SSTR2, SSTR3, SSTR4, SSTR5 |
D07431 |
Somatostatin |
2件: 67, 78 |
4件: SSTR1, SSTR2, SSTR3, SSTR5 |
D10147 |
Pasireotide |
3件: 67, 74, 75 |
1件: SSTR2 |
D00442 |
Octreotide |
8件: 67, 75, 84, 85, 89, 96, 193, 227 |
D06495 |
87 | Neurotrophin signaling pathway 1 gene, 1 drug (DrugBank) and 2 diseases shown |
1件: ABL1 |
D03252 |
Bosutinib |
2件: 2, 67 |
88 | Nicotine addiction 1 gene, 1 drug (DrugBank) and 1 disease shown |
1件: CACNA1B |
D01173 |
Cilnidipine |
1件: 67 |
89 | Non-alcoholic fatty liver disease (NAFLD) 2 genes, 1 drug (DrugBank) and 17 diseases shown |
2件: PRKAA1, PRKAA2 |
D00944 |
Metformin |
17件: 6, 13, 46, 49, 67, 75, 77, 81, 86, 113, 158, 206, 225, 233, 265, 285, 299 |
D04966 |
90 | Osteoclast differentiation 1 gene, 1 drug (DrugBank) and 17 diseases shown |
1件: PPARG |
D00945 |
Pioglitazone |
17件: 2, 6, 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299 |
D08378 |
91 | Oxytocin signaling pathway 7 genes, 4 drugs (DrugBank) and 21 diseases shown |
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D00615 |
Amlodipine |
4件: 51, 65, 67, 298 |
D02914 |
D07450 |
D01173 |
Cilnidipine |
1件: 67 |
2件: PRKAA1, PRKAA2 |
D00944 |
Metformin |
17件: 6, 13, 46, 49, 67, 75, 77, 81, 86, 113, 158, 206, 225, 233, 265, 285, 299 |
D04966 |
1件: SRC |
D03252 |
Bosutinib |
2件: 2, 67 |
92 | Pancreatic cancer 1 gene, 2 drugs (DrugBank) and 37 diseases shown |
1件: MTOR |
D02714 |
Everolimus |
9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
93 | Pathogenic Escherichia coli infection 1 gene, 1 drug (DrugBank) and 2 diseases shown |
1件: ABL1 |
D03252 |
Bosutinib |
2件: 2, 67 |
94 | Pathways in cancer 4 genes, 8 drugs (DrugBank) and 53 diseases shown |
1件: ABL1 |
D03252 |
Bosutinib |
2件: 2, 67 |
1件: AGTR1 |
D00522 |
Candesartan |
2件: 58, 67 |
D00522 |
Candesartan cilexetil |
2件: 58, 67 |
D00626 |
D00357 |
Losartan |
18件: 13, 17, 19, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 |
D08146 |
D00627 |
Telmisartan |
2件: 66, 67 |
1件: MTOR |
D02714 |
Everolimus |
9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
1件: PPARG |
D00945 |
Pioglitazone |
17件: 2, 6, 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299 |
D08378 |
95 | PD-L1 expression and PD-1 checkpoint pathway in cancer 1 gene, 2 drugs (DrugBank) and 37 diseases shown |
1件: MTOR |
D02714 |
Everolimus |
9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
96 | Phenylalanine metabolism 1 gene, 1 drug (DrugBank) and 1 disease shown |
1件: AOC3 |
D08044 |
Hydralazine |
1件: 67 |
97 | Phospholipase D signaling pathway 3 genes, 8 drugs (DrugBank) and 48 diseases shown |
1件: AGTR1 |
D00522 |
Candesartan |
2件: 58, 67 |
D00522 |
Candesartan cilexetil |
2件: 58, 67 |
D00626 |
D00357 |
Losartan |
18件: 13, 17, 19, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 |
D08146 |
D00627 |
Telmisartan |
2件: 66, 67 |
1件: AVPR2 |
D04752 |
Lixivaptan |
1件: 67 |
D01213 |
Tolvaptan |
3件: 67, 72, 225 |
1件: MTOR |
D02714 |
Everolimus |
9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
98 | PI3K-Akt signaling pathway 3 genes, 3 drugs (DrugBank) and 47 diseases shown |
1件: MTOR |
D02714 |
Everolimus |
9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
2件: PRKAA1, PRKAA2 |
D00944 |
Metformin |
17件: 6, 13, 46, 49, 67, 75, 77, 81, 86, 113, 158, 206, 225, 233, 265, 285, 299 |
D04966 |
99 | Platelet activation 1 gene, 1 drug (DrugBank) and 2 diseases shown |
1件: SRC |
D03252 |
Bosutinib |
2件: 2, 67 |
100 | PPAR signaling pathway 1 gene, 1 drug (DrugBank) and 17 diseases shown |
1件: PPARG |
D00945 |
Pioglitazone |
17件: 2, 6, 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299 |
D08378 |
101 | Prolactin signaling pathway 1 gene, 1 drug (DrugBank) and 2 diseases shown |
1件: SRC |
D03252 |
Bosutinib |
2件: 2, 67 |
102 | Prostate cancer 1 gene, 2 drugs (DrugBank) and 37 diseases shown |
1件: MTOR |
D02714 |
Everolimus |
9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
103 | Proteoglycans in cancer 2 genes, 3 drugs (DrugBank) and 37 diseases shown |
1件: MTOR |
D02714 |
Everolimus |
9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
1件: SRC |
D03252 |
Bosutinib |
2件: 2, 67 |
104 | Rap1 signaling pathway 1 gene, 1 drug (DrugBank) and 2 diseases shown |
1件: SRC |
D03252 |
Bosutinib |
2件: 2, 67 |
105 | Ras signaling pathway 1 gene, 1 drug (DrugBank) and 2 diseases shown |
1件: ABL1 |
D03252 |
Bosutinib |
2件: 2, 67 |
106 | Regulation of actin cytoskeleton 1 gene, 1 drug (DrugBank) and 2 diseases shown |
1件: SRC |
D03252 |
Bosutinib |
2件: 2, 67 |
107 | Regulation of lipolysis in adipocytes 1 gene, 1 drug (DrugBank) and 3 diseases shown |
1件: ADRB1 |
D00634 |
Bisoprolol |
3件: 67, 86, 113 |
D02342 |
108 | Relaxin signaling pathway 1 gene, 1 drug (DrugBank) and 2 diseases shown |
1件: SRC |
D03252 |
Bosutinib |
2件: 2, 67 |
109 | Renin secretion 7 genes, 10 drugs (DrugBank) and 25 diseases shown |
1件: ACE |
D08068 |
Imidapril |
1件: 67 |
D00362 |
Lisinopril |
5件: 46, 66, 67, 113, 222 |
D08131 |
D00421 |
Ramipril |
7件: 46, 49, 66, 67, 113, 218, 257 |
1件: ADRB1 |
D00634 |
Bisoprolol |
3件: 67, 86, 113 |
D02342 |
1件: AGTR1 |
D00522 |
Candesartan |
2件: 58, 67 |
D00522 |
Candesartan cilexetil |
2件: 58, 67 |
D00626 |
D00357 |
Losartan |
18件: 13, 17, 19, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 |
D08146 |
D00627 |
Telmisartan |
2件: 66, 67 |
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D00615 |
Amlodipine |
4件: 51, 65, 67, 298 |
D02914 |
D07450 |
D01173 |
Cilnidipine |
1件: 67 |
110 | Renin-angiotensin system 2 genes, 7 drugs (DrugBank) and 21 diseases shown |
1件: ACE |
D08068 |
Imidapril |
1件: 67 |
D00362 |
Lisinopril |
5件: 46, 66, 67, 113, 222 |
D08131 |
D00421 |
Ramipril |
7件: 46, 49, 66, 67, 113, 218, 257 |
1件: AGTR1 |
D00522 |
Candesartan |
2件: 58, 67 |
D00522 |
Candesartan cilexetil |
2件: 58, 67 |
D00626 |
D00357 |
Losartan |
18件: 13, 17, 19, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 |
D08146 |
D00627 |
Telmisartan |
2件: 66, 67 |
111 | Retrograde endocannabinoid signaling 5 genes, 2 drugs (DrugBank) and 4 diseases shown |
5件: CACNA1B, CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D01173 |
Cilnidipine |
1件: 67 |
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D00615 |
Amlodipine |
4件: 51, 65, 67, 298 |
D02914 |
D07450 |
112 | Salivary secretion 4 genes, 2 drugs (DrugBank) and 4 diseases shown |
3件: ADRA1A, ADRA1B, ADRA1D |
D00608 |
Doxazosin |
2件: 57, 67 |
D07874 |
1件: ADRB1 |
D00634 |
Bisoprolol |
3件: 67, 86, 113 |
D02342 |
113 | Serotonergic synapse 5 genes, 2 drugs (DrugBank) and 4 diseases shown |
5件: CACNA1B, CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D01173 |
Cilnidipine |
1件: 67 |
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D00615 |
Amlodipine |
4件: 51, 65, 67, 298 |
D02914 |
D07450 |
114 | Shigellosis 3 genes, 3 drugs (DrugBank) and 37 diseases shown |
2件: ABL1, SRC |
D03252 |
Bosutinib |
2件: 2, 67 |
1件: MTOR |
D02714 |
Everolimus |
9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
115 | Sphingolipid metabolism 1 gene, 1 drug (DrugBank) and 2 diseases shown |
1件: UGCG |
D11633 |
Venglustat |
2件: 19, 67 |
116 | Synaptic vesicle cycle 1 gene, 1 drug (DrugBank) and 1 disease shown |
1件: CACNA1B |
D01173 |
Cilnidipine |
1件: 67 |
117 | Taste transduction 1 gene, 2 drugs (DrugBank) and 4 diseases shown |
1件: CACNA1C |
D00615 |
Amlodipine |
4件: 51, 65, 67, 298 |
D02914 |
D07450 |
D01173 |
Cilnidipine |
1件: 67 |
118 | Terpenoid backbone biosynthesis 1 gene, 1 drug (DrugBank) and 9 diseases shown |
1件: HMGCR |
D00893 |
Pravastatin |
9件: 13, 46, 49, 67, 79, 96, 164, 265, 333 |
D08410 |
119 | Th17 cell differentiation 1 gene, 2 drugs (DrugBank) and 37 diseases shown |
1件: MTOR |
D02714 |
Everolimus |
9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
120 | Thermogenesis 4 genes, 4 drugs (DrugBank) and 51 diseases shown |
1件: MTOR |
D02714 |
Everolimus |
9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
1件: PPARG |
D00945 |
Pioglitazone |
17件: 2, 6, 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299 |
D08378 |
2件: PRKAA1, PRKAA2 |
D00944 |
Metformin |
17件: 6, 13, 46, 49, 67, 75, 77, 81, 86, 113, 158, 206, 225, 233, 265, 285, 299 |
D04966 |
121 | Thyroid cancer 1 gene, 1 drug (DrugBank) and 17 diseases shown |
1件: PPARG |
D00945 |
Pioglitazone |
17件: 2, 6, 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299 |
D08378 |
122 | Thyroid hormone signaling pathway 2 genes, 3 drugs (DrugBank) and 37 diseases shown |
1件: MTOR |
D02714 |
Everolimus |
9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
1件: SRC |
D03252 |
Bosutinib |
2件: 2, 67 |
123 | Tight junction 4 genes, 4 drugs (DrugBank) and 21 diseases shown |
1件: CACNA1D |
D00615 |
Amlodipine |
4件: 51, 65, 67, 298 |
D02914 |
D07450 |
D01173 |
Cilnidipine |
1件: 67 |
2件: PRKAA1, PRKAA2 |
D00944 |
Metformin |
17件: 6, 13, 46, 49, 67, 75, 77, 81, 86, 113, 158, 206, 225, 233, 265, 285, 299 |
D04966 |
1件: SRC |
D03252 |
Bosutinib |
2件: 2, 67 |
124 | Transcriptional misregulation in cancer 1 gene, 1 drug (DrugBank) and 17 diseases shown |
1件: PPARG |
D00945 |
Pioglitazone |
17件: 2, 6, 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299 |
D08378 |
125 | Tuberculosis 1 gene, 1 drug (DrugBank) and 2 diseases shown |
1件: SRC |
D03252 |
Bosutinib |
2件: 2, 67 |
126 | Type II diabetes mellitus 4 genes, 4 drugs (DrugBank) and 38 diseases shown |
3件: CACNA1B, CACNA1C, CACNA1D |
D01173 |
Cilnidipine |
1件: 67 |
2件: CACNA1C, CACNA1D |
D00615 |
Amlodipine |
4件: 51, 65, 67, 298 |
D02914 |
D07450 |
1件: MTOR |
D02714 |
Everolimus |
9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
127 | Tyrosine metabolism 1 gene, 1 drug (DrugBank) and 1 disease shown |
1件: AOC3 |
D08044 |
Hydralazine |
1件: 67 |
128 | Vascular smooth muscle contraction 8 genes, 7 drugs (DrugBank) and 22 diseases shown |
3件: ADRA1A, ADRA1B, ADRA1D |
D00608 |
Doxazosin |
2件: 57, 67 |
D07874 |
1件: AGTR1 |
D00522 |
Candesartan |
2件: 58, 67 |
D00522 |
Candesartan cilexetil |
2件: 58, 67 |
D00626 |
D00357 |
Losartan |
18件: 13, 17, 19, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 |
D08146 |
D00627 |
Telmisartan |
2件: 66, 67 |
4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D00615 |
Amlodipine |
4件: 51, 65, 67, 298 |
D02914 |
D07450 |
D01173 |
Cilnidipine |
1件: 67 |
129 | Vasopressin-regulated water reabsorption 1 gene, 2 drugs (DrugBank) and 3 diseases shown |
1件: AVPR2 |
D04752 |
Lixivaptan |
1件: 67 |
D01213 |
Tolvaptan |
3件: 67, 72, 225 |
130 | VEGF signaling pathway 1 gene, 1 drug (DrugBank) and 2 diseases shown |
1件: SRC |
D03252 |
Bosutinib |
2件: 2, 67 |
131 | Viral carcinogenesis 1 gene, 1 drug (DrugBank) and 2 diseases shown |
1件: SRC |
D03252 |
Bosutinib |
2件: 2, 67 |
132 | Viral myocarditis 1 gene, 1 drug (DrugBank) and 2 diseases shown |
1件: ABL1 |
D03252 |
Bosutinib |
2件: 2, 67 |
133 | Yersinia infection 1 gene, 1 drug (DrugBank) and 2 diseases shown |
1件: SRC |
D03252 |
Bosutinib |
2件: 2, 67 |